Shopping Cart
- Remove All
- Your shopping cart is currently empty
Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | 7-10 days |
Description | Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose conce |
Targets&IC50 | DPP4:0.6-1.3 nM (Ki) |
Alias | Saxagliptin HCl, BMS-477118 HCl, BMS 477118 HCl |
Molecular Weight | 351.87 |
Formula | C18H26ClN3O2 |
Cas No. | 709031-78-7 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.